Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety

Stress ◽  
2005 ◽  
Vol 8 (4) ◽  
pp. 209-219 ◽  
Author(s):  
Anantha Shekhar ◽  
William Truitt ◽  
Donald Rainnie ◽  
Tammy Sajdyk
2006 ◽  
Vol 12 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Ashley Craig ◽  
Yvonne Tran

Stammering results in involuntary disruption of a person's capacity to speak. It begins at an early age and can persist for life for at least 20% of those stammering at 2 years old. Although the aetiological role of anxiety in stammering has not been determined, evidence is emerging that suggests people who stammer are more chronically and socially anxious than those who do not. This is not surprising, given that the symptoms of stammering can be socially embarrassing and personally frustrating, and have the potential to impede vocational and social growth. Implications for DSM–IV diagnostic criteria for stammering and current treatments of stammering are discussed. We hope that this article will encourage a better understanding of the consequences of living with a speech or fluency disorder as well as motivate the development of treatment protocols that directly target the social fears associated with stammering.


1964 ◽  
Vol 46 (1) ◽  
pp. 71-79 ◽  
Author(s):  
Claus Rerup

ABSTRACT The possibility of elaborating a sensitive test for the determination of CRF (Corticotrophin-releasing factor) was investigated in corticosteroid-blocked mice. Two synthetic peptides known to possess corticotrophin-releasing activity (CRA) in the rat, i. e. lysine-vasopressin and histidyl-seryl-lysine-vasopressin (CRA-41) were used as test substances. The results showed that it is possible to perform quantitative estimations of CR-activity and that both the peptides tested are true corticotrophin-releasing substances in mice. Lysine-vasopressin was more potent than its synthetic histidyl-seryl-analogue both on an absolute weight basis and in terms of pressor- or corticotrophin equivalents. Threshold doses for CR-activity of lysine-vasopressin in mice were calculated to be about 4 ng (nanograms). From the findings it appears that in mice, the main blocking action of the glucocorticoid dexamethasone is exerted at hypothalamic or higher centres, and not in the cells of the anterior pituitary gland. It is proposed to abandon arbitrary units for CR-activity and to use vasopressin or hypothalamic extracts as a standard for CRF-assay. The possibility of a physiological role of vasopressin as a transmitter substance for corticotrophin-release is briefly discussed.


2000 ◽  
Vol 150 (3) ◽  
pp. 317-324 ◽  
Author(s):  
A. D. Lê ◽  
S. Harding ◽  
W. Juzytsch ◽  
J. Watchus ◽  
U. Shalev ◽  
...  

Cephalalgia ◽  
2008 ◽  
Vol 28 (7) ◽  
pp. 714-722 ◽  
Author(s):  
P Sarchielli ◽  
I Rainero ◽  
F Coppola ◽  
C Rossi ◽  
ML Mancini ◽  
...  

The study set out to investigate the role of corticotrophin-releasing factor (CRF) and orexin-A in chronic migraine (CM) and medication-overuse headache (MOH). Twenty-seven patients affected by CM and 30 with MOH were enrolled. Control CSF specimens were obtained from 20 age-matched subjects who underwent lumbar puncture for diagnostic purposes, and in all of them CSF and blood tests excluded central nervous system or systemic diseases. Orexin-A and CRF were determined by radioimmunoassay methods. Significantly higher levels of orexin-A and CRF were found in the CSF of MOH and to a lesser extent in patients with CM compared with control subjects (orexin-A: P < 0.001 and P < 0.02; CRF: P < 0.002 and P < 0.0003). A significant positive correlation was also found between CSF orexin-A values and those of CRF ( R = 0.71; P < 0.0008), monthly drug intake group ( R = 0.39; P < 0.03) and scores of a self-completion 10-item instrument to measure dependence upon a variety of substances, the Leeds Dependence Questionnaire (LDQ) in the MOH group ( R = 0.68; P < 0.0003). The significantly higher orexin-A levels found in CM and MOH can be interpreted as a compensatory response to chronic head pain or, alternatively, as an expression of hypothalamic response to stress due to chronic pain. A potential role for orexin-A in driving drug seeking in MOH patients through activation of stress pathways in the brain can also be hypothesized.


2002 ◽  
Vol 14 (6) ◽  
pp. 377 ◽  
Author(s):  
A. I. Turner ◽  
P. H. Hemsworth ◽  
A. J. Tilbrook

Although it is generally considered that stress can impair reproduction, we suggest that the impact of acute or repeated acute stress or acute or repeated acute elevations of cortisol are of little consequence in female pigs, even if these occur during the series of endocrine events that induce oestrus and ovulation. It is important to understand the impact of acute stress on reproduction because, in the intensive production of livestock, animals are often subjected to short-term challenges. There seems little doubt that reproduction in a proportion of female pigs is susceptible to impairment by severe and prolonged stress or the sustained elevation of cortisol but only when this continues for a substantial period. In female pigs, where reproduction is susceptible to impairment by severe prolonged stress, it is possible that the mediators of this suppression are cortisol, corticotrophin-releasing factor and vasopressin but, in pigs, there is evidence to suggest that adrenocorticotrophic hormone is not involved. Other substances secreted during stress may be involved but these are not considered in this review. It is possible that the mediators of stress act at any level of the hypothalamo–pituitary–ovarian axis. Although a variety of experimental manipulations have provided potential mediators and mechanisms for the stress-induced suppression of reproduction, these experimental manipulations rarely represented physiological circumstances so it is not clear if such mechanisms would be important in a physiological context. The precise mediators and mechanisms by which hormones released during stress may inhibit reproductive processes during severe prolonged stress are yet to be determined.


2011 ◽  
Vol 26 (2) ◽  
pp. 279 ◽  
Author(s):  
Young Ju Cho ◽  
Jang Hee Kim ◽  
Hyun Ee Yim ◽  
Da Mi Lee ◽  
Seon Kyo Im ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document